Topics and Expertise: personalized medicines

Allopurinol, the first-choice medication for treating gout—an excruciatingly painful condition that is the most common form of inflammatory arthritis, afflicts more than eight million Americans, and is on the rise worldwide—is not fully effective in more than half of patients.

Table of contents

Introduction
Budget significance
Reasons for past success
A decade of funding for bioinformatics
New drug discovery directions attract support
Research stalwarts draw funding for decades
New directions in translational research attract support
Expansion of the School’s...

Asthma specialist and genetics researcher, Esteban G. Burchard, MD, MPH, joint faculty member in the UCSF Schools of Pharmacy and Medicine, discusses the differences in the incidence of asthma and response to asthma drugs among various subgroups within the larger Latino population.

Leslie Z. Benet, PhD, UCSF School of Pharmacy faculty member, received the 2008 Paul Ehrlich Magic Bullet Lifetime Achievement Award at the Second World Conference on Magic Bullets, which convened in Nuremberg, Germany, in early October. The award recognized Benet's scientific accomplishments in...

The wider world use of medical tests and treatments based on individual genetic differences is the focus of a new, US$5 million research program funded by the National Cancer Institute (NCI) and led by UCSF School of Pharmacy health economist Kathryn Phillips, PhD. The grant was awarded on...

What began as a fascination with fish when he was a child eventually led Esteban Burchard, MD to study genetic differences behind asthma risk.